SG49830A1 - Vaccine design and production - Google Patents

Vaccine design and production

Info

Publication number
SG49830A1
SG49830A1 SG1996007162A SG1996007162A SG49830A1 SG 49830 A1 SG49830 A1 SG 49830A1 SG 1996007162 A SG1996007162 A SG 1996007162A SG 1996007162 A SG1996007162 A SG 1996007162A SG 49830 A1 SG49830 A1 SG 49830A1
Authority
SG
Singapore
Prior art keywords
production
vaccine design
vaccine
design
Prior art date
Application number
SG1996007162A
Other languages
English (en)
Inventor
Curtis Coas Scheifinger
David Lee Smiley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SG49830A1 publication Critical patent/SG49830A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996007162A 1993-11-05 1994-11-04 Vaccine design and production SG49830A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14776593A 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
SG49830A1 true SG49830A1 (en) 1998-06-15

Family

ID=22522813

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007162A SG49830A1 (en) 1993-11-05 1994-11-04 Vaccine design and production

Country Status (21)

Country Link
US (1) US5679349A (fr)
EP (1) EP0726774A4 (fr)
JP (1) JPH09505039A (fr)
KR (1) KR960705582A (fr)
CN (2) CN1087953C (fr)
AU (1) AU1050595A (fr)
BR (1) BR9407988A (fr)
CA (1) CA2175708A1 (fr)
CZ (1) CZ128896A3 (fr)
FI (1) FI961869A (fr)
HU (1) HUT75556A (fr)
NO (1) NO961808L (fr)
NZ (1) NZ276290A (fr)
PL (1) PL314303A1 (fr)
RO (1) RO116045B1 (fr)
RU (1) RU2143920C1 (fr)
SG (1) SG49830A1 (fr)
TW (1) TW448185B (fr)
UA (1) UA42741C2 (fr)
WO (1) WO1995012410A1 (fr)
ZA (1) ZA948590B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518458A (ja) * 1998-06-23 2002-06-25 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ アジュバント療法
JP2003171291A (ja) * 1999-10-29 2003-06-17 Takeda Schering-Plough Animal Health Kk 乳房炎用粘膜予防剤
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
GB0219524D0 (en) 2002-08-21 2002-10-02 Queen Mary & Westfield College Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
GB0802931D0 (en) 2008-02-18 2008-03-26 Queen Mary & Westfield College Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions
CN102716475A (zh) * 2012-06-29 2012-10-10 黑龙江省科学院微生物研究所 一种奶牛乳房炎疫苗的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0672123A1 (fr) * 1992-01-08 1995-09-20 The Rockefeller University Proteine de surface multifonctionnelle de streptococci

Also Published As

Publication number Publication date
EP0726774A4 (fr) 2001-06-27
BR9407988A (pt) 1996-12-03
PL314303A1 (en) 1996-09-02
CN1380422A (zh) 2002-11-20
FI961869A0 (fi) 1996-05-02
KR960705582A (ko) 1996-11-08
CN1141000A (zh) 1997-01-22
NZ276290A (en) 1997-11-24
ZA948590B (en) 1996-05-02
CA2175708A1 (fr) 1995-05-11
TW448185B (en) 2001-08-01
UA42741C2 (uk) 2001-11-15
RU2143920C1 (ru) 2000-01-10
HU9601191D0 (en) 1996-06-28
NO961808D0 (no) 1996-05-03
AU1050595A (en) 1995-05-23
FI961869A (fi) 1996-05-02
NO961808L (no) 1996-06-27
WO1995012410A1 (fr) 1995-05-11
EP0726774A1 (fr) 1996-08-21
CN1087953C (zh) 2002-07-24
JPH09505039A (ja) 1997-05-20
RO116045B1 (ro) 2000-10-30
CZ128896A3 (en) 1996-10-16
US5679349A (en) 1997-10-21
HUT75556A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
HK1010974A1 (en) Ornament
GB9102315D0 (en) Oxides and the production thereof
ZA947828B (en) Vaccines
GB9401026D0 (en) Solutions and their preparation
GB2276806B (en) Ornament
GB9325496D0 (en) Vaccines
SG49853A1 (en) Novel macrolides and the use thereof
GB2281830B (en) I/q-modulator and i/q-demodulator
EP0549801A4 (en) Diamond-covered member and production thereof
HU9601191D0 (en) Vaccine design and production
GB9321673D0 (en) Pillows
GB9322702D0 (en) Vaccines
ZA948729B (en) Vaccines
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
EP0505941A3 (en) Peptifluorin and neopeptifluorin
AU1122692A (en) Stockfeed and the production thereof
GB9212816D0 (en) Vaccines and their uses
GB9323754D0 (en) Vaccine
GB9323820D0 (en) Vaccine
GB9306398D0 (en) Vaccines
GB9304056D0 (en) Vaccines
GB9312641D0 (en) Vaccines
GB9314520D0 (en) Vaccines
GB9315098D0 (en) Vaccines
GB9304269D0 (en) Aerogel-containing galzing unit and manufacture thereof